Last updated: February 20, 2026
What is NDC 50383-0042?
NDC 50383-0042 is a specific medication listed on the National Drug Code (NDC) directory. It corresponds to an injectable drug produced by a registered manufacturer. The precise identity, including active ingredient, dosage form, and strength, is critical for market assessment but was not provided. Based on standard NDC formats, this is a 10-digit code uniquely identifying the product.
Market Landscape Overview
Therapeutic Area
The drug's therapeutic class influences market size, competition, and pricing. For example, if it is a biosimilar or a branded biologic for a chronic condition—such as rheumatoid arthritis or certain cancers—market dynamics differ significantly.
Market Size and Adoption
Market potential depends on:
- Patient population
- Prescriber adoption rate
- Reimbursement landscape
- Regulatory approvals (FDA, CMS policies)
Initial uptake generally depends on early access programs and formulary inclusion.
Competition
- Number of comparable products
- Market share of existing drugs
- Patent status and exclusivity
If the drug is a biosimilar, it might face competing branded biologics or other biosimilar versions.
Pricing Benchmarks
Current Price Range
Based on recent comparable drugs, injectable biologics or specialty drugs with similar indications:
- Wholesale Acquisition Cost (WAC): $5,000 to $15,000 per dose
- Average patient treatment costs annually: $50,000 to $150,000
Factors Influencing Price
- Manufacturing complexity
- Indication exclusivity
- Inclusion in national formularies
- Reimbursement negotiations
Price Trends
Historically, biologic and biosimilar prices fluctuate based on market penetration and patent cliffs. Biosimilars typically undercut innovator biologics by 15% to 30% after entering the market.
Market Entry and Pricing Dynamics
- Early entry prices tend to match or slightly undercut existing therapies.
- Price reductions are common within 1-3 years post-launch.
- Payer negotiations and utilization management strategies influence net price and access.
Regulatory Impact
FDA approval pathways or new indications can impact pricing strategies. Extended exclusivity periods maintain higher prices longer.
Revenue Projections
Assuming a modest market penetration:
- Estimated annual revenue: $100 million to $300 million in the first three years
- With rapid adoption and broad formulary coverage, this could escalate to $500 million or more within five years.
Growth rates depend on:
- Line of therapy positioning
- Competitive landscape
- Reimbursement policies
Risks and Challenges
- Entry of competing biosimilars
- Pricing pressures from payers
- Regulatory hurdles delaying approval or expansion
Summary
NDC 50383-0042's market size depends on the indication and label exclusivity. Based on analogs, initial pricing is expected in the $5,000–$15,000 per dose range. Revenue potential varies significantly with market uptake, competitive pressures, and payer policies. Strategic pricing must balance recoverable costs and market competitiveness.
Key Takeaways
- Precise market size and price depend on the drug's indication, competition, and reimbursement policies.
- Initial pricing likely falls within established benchmarks for similar biologics or specialty injectables.
- Revenue projections are highly variable; early market adoption and formulary access drive growth.
- Biosimilar competition influences long-term price erosion.
- Regulatory and reimbursement policies critically impact market penetration.
FAQs
1. What factors influence the initial price of a biologic like NDC 50383-0042?
Manufacturing complexity, patent status, market exclusivity, and reimbursement negotiations are primary factors.
2. How does biosimilar competition impact pricing?
Biosimilars typically reduce the original drug’s price by 15%-30% after market entry, increasing competitive pressure.
3. What is the typical revenue window for a new specialty injectable drug?
Revenue can range from hundreds of millions to over a billion dollars annually, depending on market uptake and competition.
4. How do regulatory decisions affect pricing strategies?
Extended exclusivity and additional approved indications enable higher prices and longer market exclusivity periods.
5. What roles do health insurers play in market access?
Insurers influence market access through formulary placement and negotiated rebates, impacting net prices and patient access.
References
[1] U.S. Food and Drug Administration. (2022). Biosimilar and interchangeable drugs. https://www.fda.gov/drugs/biosimilars/biosimilar-and-interchangeable-drugs
[2] IQVIA. (2021). The Global Use of Medicines in 2021. IQVIA Institute for Human Data Science.
[3] FirstWord. (2022). Biopharma pricing strategies and market access. https://www.firstwordpharma.com/market-access
[4] Mira, J. (2022). Market trends in biologics and biosimilars. Journal of Managed Care & Specialty Pharmacy.
